B4B aims to develop new and innovative therapeutic strategies to cross the Blood-Brain Barrier.
At present B4B involves more than 60 universities from 15 European countries, The United States, Australia, and Brazil. B4B works in strong collaboration with many other Institutions, Patient Associations and Professional Organisations such as the European Brain Council (EBC), ORPHANET and the European Study Group for Lysosomal Diseases (ESGLD).
BtRAIN fellows will have the opportunity to build sustainable contacts within this international network.

More here »